Bank of New York Mellon’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,244
| Closed | -$46K | – | 4629 |
|
|
2022
Q1 | $46K | Hold |
1,244
| – | – | ﹤0.01% | 4533 |
|
|
2021
Q4 | $67K | Sell |
1,244
-150
| -11% | -$8.08K | ﹤0.01% | 4457 |
|
|
2021
Q3 | $103K | Buy |
1,394
+290
| +26% | +$21.4K | ﹤0.01% | 4323 |
|
|
2021
Q2 | $928K | Buy |
+1,104
| New | +$928K | ﹤0.01% | 3466 |
|
|
2021
Q1 | – | Sell |
-234
| Closed | -$213K | – | 4332 |
|
|
2020
Q4 | $213K | Buy |
+234
| New | +$213K | ﹤0.01% | 3956 |
|
|
2020
Q2 | – | Sell |
-120
| Closed | -$55K | – | 4108 |
|
|
2020
Q1 | $55K | Hold |
120
| – | – | ﹤0.01% | 3954 |
|
|
2019
Q4 | $24K | Sell |
120
-43
| -26% | -$8.6K | ﹤0.01% | 4143 |
|
|
2019
Q3 | $41K | Sell |
163
-32
| -16% | -$8.05K | ﹤0.01% | 4131 |
|
|
2019
Q2 | $489K | Buy |
195
+31
| +19% | +$77.7K | ﹤0.01% | 3614 |
|
|
2019
Q1 | $667K | Buy |
164
+12
| +8% | +$48.8K | ﹤0.01% | 3405 |
|
|
2018
Q4 | $468K | Buy |
152
+11
| +8% | +$33.9K | ﹤0.01% | 3516 |
|
|
2018
Q3 | $824K | Buy |
141
+16
| +13% | +$93.5K | ﹤0.01% | 3375 |
|
|
2018
Q2 | $438K | Sell |
125
-17
| -12% | -$59.6K | ﹤0.01% | 3683 |
|
|
2018
Q1 | $630K | Buy |
142
+4
| +3% | +$17.7K | ﹤0.01% | 3456 |
|
|
2017
Q4 | $532K | Buy |
138
+65
| +89% | +$251K | ﹤0.01% | 3588 |
|
|
2017
Q3 | $343K | Buy |
73
+11
| +18% | +$51.7K | ﹤0.01% | 3712 |
|
|
2017
Q2 | $281K | Buy |
+62
| New | +$281K | ﹤0.01% | 3834 |
|